CD4 and neoplasm: In the present study, we show that the presentation of MSLN-derived HLA class II-restricted peptides in the immunopeptidome is associated with longer patient survival, providing important insights into the role of immunopeptidome-guided CD4+ T-cell responses for tumor immune surveillance in OvCa.